This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Health Care

Shades of 1990s in Social Media Earnings Misses: Best of Kass

Shades of 1990s in Social Media Earnings Misses: Best of Kass

In highlights from his trading diary of the past week, Kass pointed to similarities between high-profile social media and biotech earnings misses and certain Internet stocks in the late 1990s.

05/03/15 - 04:53 PM EDT

One Way Companies Can Trim Long-Term Health Care Costs

Self-insured companies don't pay premiums and can engage firms to negotiate better deals on medicals bills on their behalf.

05/01/15 - 01:46 PM EDT

Try Jim Cramer's Action Alerts PLUS
CVS Beats Analyst Estimates, Aided by Pharmacy Services and Claims

CVS Beats Analyst Estimates, Aided by Pharmacy Services and Claims

  • Tickers in this article:
  • CVS

Shares of CVS Health (CVS) are rising in Friday trading after the drugstore operator reported better-than-expected first-quarter earnings.

05/01/15 - 12:18 PM EDT

May 1 Premarket Briefing: 10 Things You Should Know

May 1 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are moving upward Friday as investors await earnings from CVS and Berkshire Hathaway.

05/01/15 - 08:24 AM EDT

IBM Throws Spotlight on Software Companies in Health Data

IBM Throws Spotlight on Software Companies in Health Data

Data and analytics used in preventative health care is becoming a bigger business as a deal IBM announced this month shows.

04/30/15 - 10:32 AM EDT

April 30 Premarket Briefing: 10 Things You Should Know

April 30 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are sagging as investors consider the Federal Reserve's Open Market Committee announcement from Wednesday and await data on unemployment and manufacturing Thursday.

04/30/15 - 07:55 AM EDT

MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales

MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales

  • Tickers in this article:
  • MNKD
  • SNY

Sales of MannKind's inhaled insulin Afrezza totaled €1 million in the first quarter of its commercial launch.

04/30/15 - 06:51 AM EDT

Medical Corps President Talks Donation Tech and Nepal Outreach

Medical Corps President Talks Donation Tech and Nepal Outreach

  • Tickers in this article:
  • FB

President & CEO of The International Medical Corps, Nancy Aossey, says that the damage done by the earthquake in Nepal is unquantifiable.

04/29/15 - 06:01 PM EDT

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings

Looking at Mannkind's Afrezza Sales Estimates Ahead of Sanofi Earnings

  • Tickers in this article:
  • MNKD
  • SNY

Sanofi reports first-quarter earnings on Thursday morning, but it's unclear if sales of the recently launched inhaled insulin medication Afrezza will be disclosed.

04/29/15 - 01:18 PM EDT

April 29 Premarket Briefing: 10 Things You Should Know

April 29 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are a bit lower as investors focus on this afternoon's Federal Reserve Open Market Committee announcement.

04/29/15 - 07:29 AM EDT

3 Mid-Cap Pharmaceutical Companies to Add to Your Portfolio

3 Mid-Cap Pharmaceutical Companies to Add to Your Portfolio

Pharmaceutical companies can be risky investments, yet some of these stocks do have upsides.

04/28/15 - 09:15 AM EDT

April 28 Premarket Briefing: 10 Things You Should Know

April 28 Premarket Briefing: 10 Things You Should Know

U.S. stock futures are sinking as concern over the Federal Reserve's Open Market Committee meeting seemed to offset Apple's strong earnings results.

04/28/15 - 08:36 AM EDT

First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast

First-Quarter Sales of Bristol-Myers' Cancer Immunotherapy Drug Miss Street Forecast

  • Tickers in this article:
  • BMY

Overall, Bristol sales in the March quarter were $4 billion, a 6% increase from one year ago and higher than consensus.

04/28/15 - 08:11 AM EDT

Merck Sales of New Cancer Immunotherapy Top Street Estimates

Merck Sales of New Cancer Immunotherapy Top Street Estimates

  • Tickers in this article:
  • MRK

On an adjusted basis, Merck reported first quarter earnings per share of 85 cents, topping the Street consensus of 74 cents per share.

04/28/15 - 07:51 AM EDT

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Markets

DOW 18,024.06 +183.54 1.03%
S&P 500 2,108.29 +22.78 1.09%
NASDAQ 5,005.3910 +63.9670 1.29%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs